Article Information
History
- March 3, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Patricia Combes1,
- Maxime Bisseux2,3,
- Antonin Bal4,5,
- Pierre Marin2,
- Christine Archimbaud2,3,
- Amélie Brebion2,
- Hélène Chabrolles2,3,
- Christel Regagnon2,
- Jérémy Lafolie6,
- Gregory Destras4,5,
- Bruno Simon4,5,
- Laurence Josset4,5,
- Cécile Henquell2,3 and
- Audrey Mirand2,3,*
- 1CHU Clermont-Ferrand, pôle BMAP, F-63003 Clermont-Ferrand, France
- 2CHU Clermont-Ferrand, 3IHP, Virology laboratory, National Reference Centre for Enteroviruses and parechoviruses-associated laboratory, F-63003 Clermont-Ferrand, France
- 3Université Clermont Auvergne, CNRS 6023-LMGE, EPIE, F-63001 Clermont-Ferrand, France
- 4GenEPII Sequencing Platform, Institut des Agents Infectieux, Hospices Civils de Lyon, F-69004 Lyon, France
- 5CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, F-69007 Lyon, France
- 6CH Vichy, Laboratory Department, F-03000 Vichy, France
- ↵*Corresponding author:
Audrey Mirand, amirand{at}chu-clermontferrand.fr, Phone number: 33 4 73 754 850 Fax number: 33 4 73 754 851
Posted March 03, 2022.
Evidence of co-infection during Delta and Omicron variants of concern co-circulation, weeks 49-2021 to 02-2022, France
